Cancer Incidence and Mortality for All Sites of Cancer, Suffolk County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer	Incidence									Mortality
	Males and Females			Males			Females			Males and Females			Males			Females
	Average Annual Cases	Rate per 100,000 Population	95% CI	Average Annual Cases	Rate per 100,000 Males	95% CI	Average Annual Cases	Rate per 100,000 Females	95% CI	Average Annual Deaths	Rate per 100,000 Population	95% CI	Average Annual Deaths	Rate per 100,000 Males	95% CI	Average Annual Deaths	Rate per 100,000 Females	95% CI
All Invasive Malignant Tumors	9,997.2	522.0	517.3-526.7	5,067.2	571.8	564.6-579.1	4,930.0	489.6	483.3-496.0	2,679.2	136.1	133.7-138.5	1,339.8	156.8	153.0-160.7	1,339.4	122.0	119.1-125.1
Oral cavity and pharynx
All Oral cavity and pharynx	237.4	12.0	11.4-12.8	161.8	17.6	16.4-18.9	75.6	7.3	6.5-8.1	37.2	2.0	1.7-2.3	25.4	3.0	2.5-3.5	11.8	1.1	0.9-1.5
Lip	8.0	0.4	0.3-0.5	5.6	0.6	0.4-0.9	2.4	0.2	0.1-0.4	0.2	0.0	0.0-0.1	0.0	0.0	0.0-0.1	0.2	0.0	0.0-0.1
Tongue	77.8	3.9	3.5-4.3	55.6	5.9	5.2-6.6	22.2	2.1	1.7-2.6	10.2	0.6	0.4-0.7	6.8	0.8	0.6-1.2	3.4	0.3	0.2-0.6
Salivary gland	31.4	1.7	1.4-1.9	16.8	2.0	1.6-2.5	14.6	1.5	1.1-1.9	2.8	0.1	0.1-0.2	1.8	0.2	0.1-0.4	1.0	0.1	0.0-0.3
Floor of mouth	11.0	0.5	0.4-0.7	6.0	0.6	0.4-0.9	5.0	0.4	0.3-0.7	0.8	0.0	0.0-0.1	0.4	0.0	0.0-0.2	0.4	0.0	0.0-0.1
Gum & other mouth	30.6	1.6	1.3-1.9	17.0	1.9	1.5-2.4	13.6	1.3	1.0-1.7	7.0	0.3	0.2-0.5	3.8	0.4	0.3-0.7	3.2	0.3	0.2-0.5
Nasopharynx	7.8	0.4	0.3-0.6	4.8	0.6	0.4-0.9	3.0	0.3	0.2-0.6	2.8	0.2	0.1-0.3	2.0	0.3	0.1-0.5	0.8	0.1	0.0-0.3
Tonsil	47.2	2.4	2.1-2.7	39.4	4.1	3.6-4.8	7.8	0.7	0.5-1.0	2.6	0.1	0.1-0.2	2.4	0.3	0.1-0.5	0.2	0.0	0.0-0.1
Oropharynx	11.8	0.6	0.5-0.8	8.4	0.9	0.6-1.2	3.4	0.3	0.2-0.6	3.4	0.2	0.1-0.3	3.0	0.3	0.2-0.6	0.4	0.0	0.0-0.2
Hypopharynx	8.8	0.5	0.3-0.6	6.4	0.7	0.5-1.1	2.4	0.2	0.1-0.4	1.2	0.1	0.0-0.2	1.0	0.1	0.0-0.3	0.2	0.0	0.0-0.2
Other buccal cavity and pharynx	3.0	0.2	0.1-0.3	1.8	0.2	0.1-0.4	1.2	0.1	0.0-0.3	6.2	0.3	0.2-0.5	4.2	0.5	0.3-0.8	2.0	0.2	0.1-0.3
Digestive system
All Digestive system	1,657.2	85.3	83.4-87.2	911.4	102.6	99.6-105.7	745.8	71.2	68.8-73.6	723.4	36.6	35.4-37.9	402.2	46.1	44.0-48.2	321.2	29.1	27.7-30.6
Esophagus	89.2	4.4	4.0-4.8	70.2	7.5	6.7-8.4	19.0	1.7	1.4-2.1	71.4	3.5	3.1-3.9	56.6	6.2	5.5-7.0	14.8	1.3	1.0-1.7
Stomach	146.6	7.6	7.0-8.2	85.2	9.6	8.7-10.6	61.4	6.0	5.3-6.7	54.0	2.7	2.4-3.1	29.0	3.3	2.8-3.9	25.0	2.3	1.9-2.8
Small intestine	57.4	3.0	2.6-3.3	30.2	3.3	2.8-3.9	27.2	2.7	2.3-3.2	9.2	0.5	0.4-0.7	4.2	0.5	0.3-0.7	5.0	0.5	0.3-0.7
Colorectal	755.2	39.5	38.2-40.8	398.0	45.6	43.5-47.7	357.2	34.5	32.9-36.2	227.2	11.6	11.0-12.4	117.4	13.9	12.8-15.1	109.8	9.9	9.1-10.8
Colon excluding rectum	535.4	28.0	26.9-29.1	266.6	30.8	29.1-32.5	268.8	25.7	24.3-27.2	181.4	9.3	8.7-9.9	91.4	10.8	9.8-11.9	90.0	8.1	7.4-9.0
Cecum	104.6	5.3	4.8-5.8	49.2	5.6	4.9-6.4	55.4	5.0	4.4-5.7
Appendix	39.4	2.4	2.0-2.7	15.2	1.9	1.5-2.4	24.2	2.8	2.3-3.3
Ascending colon	102.6	5.3	4.8-5.8	47.4	5.6	4.9-6.3	55.2	5.1	4.5-5.7
Hepatic flexure	22.6	1.1	0.9-1.4	11.6	1.3	1.0-1.7	11.0	1.0	0.7-1.3
Transverse colon	47.8	2.4	2.1-2.8	26.2	3.0	2.5-3.6	21.6	2.0	1.6-2.4
Splenic flexure	13.4	0.7	0.6-0.9	6.6	0.8	0.5-1.1	6.8	0.7	0.5-1.0
Descending colon	36.6	2.0	1.7-2.3	21.2	2.5	2.1-3.1	15.4	1.5	1.2-1.9
Sigmoid colon	138.0	7.2	6.6-7.8	74.4	8.3	7.4-9.2	63.6	6.3	5.6-7.1
Large intestine, NOS	30.4	1.6	1.3-1.8	14.8	1.8	1.4-2.2	15.6	1.4	1.1-1.8
Rectum & rectosigmoid	219.8	11.5	10.8-12.2	131.4	14.8	13.6-16.0	88.4	8.8	8.0-9.7	45.8	2.3	2.0-2.7	26.0	3.1	2.6-3.7	19.8	1.8	1.4-2.2
Rectosigmoid junction	57.0	3.0	2.7-3.4	32.8	3.7	3.2-4.4	24.2	2.4	1.9-2.9
Rectum	162.8	8.5	7.9-9.1	98.6	11.0	10.1-12.1	64.2	6.4	5.7-7.2
Anus, anal canal & anorectum	40.2	2.1	1.8-2.4	13.8	1.5	1.2-1.9	26.4	2.6	2.2-3.1	5.0	0.2	0.2-0.4	2.6	0.3	0.1-0.5	2.4	0.2	0.1-0.4
Liver and intrahepatic bile duct	155.6	7.7	7.1-8.3	109.8	11.8	10.8-12.9	45.8	4.2	3.7-4.9	98.2	4.9	4.5-5.4	64.6	7.2	6.4-8.0	33.6	3.0	2.6-3.5
Liver	121.6	6.0	5.5-6.5	92.2	9.8	8.9-10.7	29.4	2.8	2.3-3.3	65.0	3.2	2.9-3.6	49.4	5.5	4.8-6.2	15.6	1.4	1.1-1.8
Intrahepatic bile duct	34.0	1.7	1.5-2.0	17.6	2.1	1.6-2.6	16.4	1.5	1.2-1.9	33.2	1.7	1.4-2.0	15.2	1.7	1.3-2.2	18.0	1.6	1.3-2.0
Gallbladder	23.0	1.2	1.0-1.5	8.6	1.0	0.7-1.4	14.4	1.4	1.1-1.7	9.6	0.5	0.4-0.7	3.6	0.4	0.2-0.7	6.0	0.5	0.4-0.8
Other biliary	34.6	1.8	1.5-2.1	18.2	2.1	1.7-2.6	16.4	1.6	1.3-2.0	12.4	0.6	0.5-0.8	7.2	0.9	0.6-1.2	5.2	0.5	0.3-0.7
Pancreas	315.2	16.0	15.2-16.9	159.2	18.0	16.7-19.3	156.0	14.4	13.4-15.5	221.8	11.3	10.6-12.0	110.6	12.6	11.6-13.8	111.2	10.1	9.3-11.0
Retroperitoneum	8.2	0.5	0.3-0.6	4.8	0.6	0.4-0.9	3.4	0.4	0.2-0.6	1.2	0.1	0.0-0.1	0.6	0.1	0.0-0.2	0.6	0.1	0.0-0.2
Peritoneum, omentum & mesentery	7.8	0.4	0.3-0.5	1.0	0.1	0.0-0.3	6.8	0.6	0.4-0.9	5.2	0.3	0.2-0.4	1.0	0.1	0.0-0.3	4.2	0.4	0.2-0.6
Other digestive organs	24.2	1.2	1.0-1.5	12.4	1.4	1.1-1.8	11.8	1.1	0.8-1.4	8.2	0.4	0.3-0.6	4.8	0.6	0.4-0.9	3.4	0.3	0.2-0.5
Respiratory system
All Respiratory system	1,326.2	66.8	65.2-68.5	632.8	72.2	69.6-74.8	693.4	63.3	61.2-65.5	612.8	30.8	29.7-32.0	305.4	35.4	33.6-37.3	307.4	27.6	26.2-29.0
Nasal cavity, middle ear & sinuses	15.2	0.8	0.6-1.0	9.6	1.1	0.8-1.4	5.6	0.6	0.4-0.9	1.8	0.1	0.0-0.2	1.2	0.1	0.0-0.3	0.6	0.1	0.0-0.2
Larynx	58.0	2.9	2.5-3.2	46.6	5.1	4.5-5.8	11.4	1.1	0.8-1.4	15.6	0.8	0.6-1.0	12.2	1.4	1.0-1.8	3.4	0.3	0.2-0.5
Lung and bronchus	1,249.6	62.9	61.4-64.5	573.6	65.6	63.2-68.1	676.0	61.6	59.5-63.8	594.0	29.9	28.8-31.0	291.2	33.8	32.1-35.7	302.8	27.2	25.8-28.6
Pleura	0.2	0.0	0.0-0.1	0.2	0.0	0.0-0.1	0.0	0.0	0.0-0.1	1.0	0.1	0.0-0.1	0.6	0.1	0.0-0.2	0.4	0.0	0.0-0.2
Trachea, mediastinum, other respiratory	3.2	0.2	0.1-0.4	2.8	0.4	0.2-0.7	0.4	0.1	0.0-0.2	0.4	0.0	0.0-0.1	0.2	0.0	0.0-0.2	0.2	0.0	0.0-0.1
Soft tissue, bone, and skin
Bones & joints	20.8	1.4	1.1-1.7	10.0	1.4	1.0-1.8	10.8	1.4	1.0-1.9	6.8	0.4	0.3-0.6	4.2	0.5	0.3-0.8	2.6	0.3	0.2-0.6
Soft tissue (including heart)	67.6	3.8	3.4-4.3	36.8	4.4	3.7-5.1	30.8	3.4	2.8-4.0	27.6	1.5	1.2-1.7	14.4	1.7	1.3-2.1	13.2	1.3	1.0-1.7
Skin~	518.8	27.2	26.2-28.3	311.2	35.9	34.1-37.8	207.6	20.9	19.6-22.3	57.6	2.9	2.6-3.3	39.2	4.6	4.0-5.3	18.4	1.6	1.3-2.0
Melanoma of the skin	474.4	24.9	23.9-25.9	283.2	32.4	30.7-34.2	191.2	19.3	18.1-20.7	38.0	1.9	1.6-2.2	25.2	2.9	2.4-3.5	12.8	1.2	0.9-1.5
Breast
Breast	1,383.6	74.6	72.8-76.4	12.4	1.4	1.0-1.8	1,371.2	139.9	136.4-143.4	193.4	9.9	9.3-10.6	2.2	0.3	0.1-0.5	191.2	17.8	16.6-19.0
Breast (in situ)*	420.0	23.3	22.3-24.4	0.8	0.1	0.0-0.2	419.2	44.8	42.8-46.8
Female genital system
All Female genital system							577.4	56.4	54.2-58.5							157.2	14.6	13.5-15.6
Cervix uteri							46.0	5.5	4.8-6.4							13.4	1.5	1.1-1.9
Corpus uterus and NOS							341.8	32.2	30.6-33.8							61.2	5.7	5.0-6.4
Ovary							121.2	12.2	11.2-13.2							71.8	6.5	5.8-7.2
Vagina							7.2	0.7	0.5-1.0							2.2	0.2	0.1-0.4
Vulva							27.2	2.5	2.1-3.0							6.0	0.5	0.3-0.7
Other female genital organs							34.0	3.2	2.7-3.8							2.6	0.2	0.1-0.4
Male genital system
All Male genital system				1,374.4	146.5	143.0-150.1							133.8	16.4	15.2-17.8
Prostate				1,316.4	138.2	134.9-141.7							129.8	15.9	14.7-17.2
Testis				50.2	7.3	6.4-8.3							2.2	0.3	0.1-0.5
Penis				6.2	0.7	0.5-1.1							1.2	0.2	0.1-0.3
Other male genital organs				1.6	0.2	0.1-0.4							0.6	0.1	0.0-0.3
Urinary system
All Urinary system	908.8	46.8	45.4-48.2	638.6	73.5	71.0-76.2	270.2	25.5	24.1-27.0	150.0	7.6	7.0-8.1	103.0	12.5	11.4-13.6	47.0	4.1	3.6-4.7
Urinary bladder (including in situ)	522.0	26.7	25.7-27.8	389.2	45.5	43.5-47.7	132.8	12.2	11.2-13.1	93.8	4.8	4.3-5.2	67.0	8.3	7.4-9.3	26.8	2.3	1.9-2.7
Kidney and renal pelvis	366.0	19.1	18.2-20.0	233.8	26.2	24.6-27.8	132.2	12.9	11.9-14.0	51.6	2.6	2.3-2.9	33.4	3.8	3.3-4.5	18.2	1.6	1.3-2.0
Ureter	12.6	0.6	0.5-0.8	8.8	1.0	0.8-1.4	3.8	0.3	0.2-0.5	2.0	0.1	0.0-0.2	0.4	0.1	0.0-0.2	1.6	0.1	0.1-0.3
Other urinary organs	8.2	0.4	0.3-0.6	6.8	0.8	0.6-1.1	1.4	0.1	0.1-0.3	2.6	0.1	0.1-0.2	2.2	0.3	0.1-0.5	0.4	0.0	0.0-0.2
Eye & orbit
Eye & orbit	19.2	1.1	0.8-1.3	11.0	1.2	0.9-1.6	8.2	0.9	0.6-1.3	2.0	0.1	0.0-0.2	0.8	0.1	0.0-0.2	1.2	0.1	0.0-0.3
Brain and central nervous system
All Brain / other central nervous system (all behaviors)	462.4	25.7	24.7-26.9	180.4	22.0	20.5-23.5	282.0	29.0	27.4-30.7	95.6	4.9	4.5-5.4	52.2	5.8	5.1-6.6	43.4	4.1	3.5-4.7
Malignant brain / other central nervous system	124.6	7.3	6.7-7.9	65.2	8.0	7.1-8.9	59.4	6.6	5.9-7.5	81.4	4.2	3.8-4.6	45.2	5.0	4.4-5.7	36.2	3.5	3.0-4.0
Malignant brain	119.4	6.9	6.4-7.6	62.8	7.7	6.8-8.6	56.6	6.3	5.5-7.1
Malignant other central nervous system	5.2	0.3	0.2-0.5	2.4	0.3	0.1-0.5	2.8	0.3	0.2-0.6
Benign brain / other central nervous system*	337.8	18.5	17.6-19.4	115.2	14.0	12.9-15.2	222.6	22.4	21.0-23.8	14.2	0.7	0.6-0.9	7.0	0.8	0.6-1.1	7.2	0.6	0.4-0.9
Benign brain	41.6	2.7	2.3-3.1	22.0	2.9	2.4-3.5	19.6	2.4	2.0-3.0
Benign other central nervous system	296.2	15.8	15.0-16.7	93.2	11.1	10.1-12.2	203.0	19.9	18.7-21.3
Endocrine system
All Endocrine system	364.0	22.7	21.6-23.8	114.6	13.8	12.7-15.1	249.4	31.4	29.6-33.3	15.8	0.8	0.6-1.0	5.6	0.6	0.4-0.9	10.2	0.9	0.7-1.3
Thyroid	342.8	21.4	20.4-22.5	103.8	12.5	11.4-13.7	239.0	30.3	28.5-32.1	11.4	0.6	0.4-0.8	4.0	0.5	0.3-0.7	7.4	0.7	0.5-1.0
Other endocrine (including thymus)	21.2	1.2	1.0-1.5	10.8	1.3	1.0-1.7	10.4	1.2	0.9-1.6	4.4	0.2	0.1-0.4	1.6	0.2	0.1-0.4	2.8	0.3	0.1-0.5
Lymphomas
All Lymphomas	481.6	26.1	25.0-27.2	260.4	30.7	29.0-32.5	221.2	22.5	21.1-23.9	95.4	4.9	4.5-5.4	53.6	6.4	5.6-7.2	41.8	3.9	3.3-4.4
Hodgkin lymphoma	53.8	3.4	3.0-3.9	27.8	3.5	3.0-4.2	26.0	3.4	2.8-4.0	4.6	0.3	0.2-0.4	2.2	0.3	0.1-0.5	2.4	0.3	0.1-0.5
Non-Hodgkin lymphomas	427.8	22.6	21.7-23.7	232.6	27.2	25.6-28.8	195.2	19.1	17.9-20.4	90.8	4.6	4.2-5.1	51.4	6.1	5.4-6.9	39.4	3.6	3.1-4.2
Myeloma
All Myeloma	160.0	8.2	7.6-8.8	91.8	10.3	9.4-11.4	68.2	6.4	5.7-7.1	51.2	2.5	2.2-2.9	29.0	3.4	2.8-4.0	22.2	1.9	1.6-2.3
Leukemias
All Leukemias	356.8	19.3	18.3-20.2	209.8	24.8	23.3-26.4	147.0	14.8	13.7-15.9	109.0	5.7	5.2-6.2	64.2	7.9	7.0-8.8	44.8	4.1	3.6-4.7
Lymphocytic leukemias	202.8	10.8	10.2-11.5	121.8	14.1	13.0-15.3	81.0	8.1	7.3-9.0	28.4	1.5	1.2-1.7	16.4	2.0	1.6-2.5	12.0	1.0	0.8-1.4
Acute lymphocytic leukemia	28.2	2.0	1.7-2.4	15.4	2.2	1.7-2.8	12.8	1.8	1.4-2.3	5.0	0.3	0.2-0.4	2.8	0.3	0.2-0.6	2.2	0.3	0.1-0.5
Chronic lymphocytic leukemia	162.6	8.2	7.6-8.8	97.6	10.9	9.9-11.9	65.0	6.0	5.3-6.7	21.6	1.1	0.9-1.3	12.2	1.5	1.2-2.0	9.4	0.8	0.6-1.0
Other lymphocytic leukemias	12.0	0.6	0.5-0.8	8.8	1.0	0.7-1.4	3.2	0.3	0.2-0.5	1.8	0.1	0.0-0.2	1.4	0.2	0.1-0.3	0.4	0.0	0.0-0.2
Myeloid and monocytic leukemias	138.8	7.6	7.0-8.2	79.6	9.7	8.8-10.8	59.2	6.0	5.3-6.8	62.0	3.3	2.9-3.7	36.8	4.5	3.9-5.2	25.2	2.4	1.9-2.8
Acute myeloid leukemia	88.6	4.8	4.4-5.3	49.8	6.0	5.3-6.8	38.8	4.0	3.4-4.7	53.6	2.8	2.5-3.2	30.8	3.7	3.2-4.4	22.8	2.1	1.7-2.5
Acute monocytic leukemia	4.2	0.2	0.1-0.4	2.4	0.3	0.2-0.5	1.8	0.2	0.1-0.4	0.4	0.0	0.0-0.1	0.2	0.0	0.0-0.2	0.2	0.0	0.0-0.1
Chronic myeloid leukemia	43.8	2.4	2.1-2.8	26.4	3.3	2.8-4.0	17.4	1.7	1.4-2.1	4.8	0.3	0.2-0.4	3.4	0.4	0.3-0.7	1.4	0.2	0.1-0.3
Other myeloid/monocytic leukemias	2.2	0.1	0.1-0.2	1.0	0.1	0.0-0.3	1.2	0.1	0.0-0.3	3.2	0.2	0.1-0.3	2.4	0.3	0.1-0.5	0.8	0.1	0.0-0.2
Other leukemias	15.2	0.8	0.6-1.0	8.4	1.0	0.7-1.4	6.8	0.7	0.4-0.9	18.6	1.0	0.8-1.2	11.0	1.3	1.0-1.8	7.6	0.7	0.5-1.0
Other acute leukemias	5.8	0.3	0.2-0.5	3.2	0.4	0.2-0.7	2.6	0.3	0.1-0.5	9.2	0.5	0.3-0.6	4.8	0.6	0.4-0.9	4.4	0.4	0.3-0.6
Aleukemic, subacute, leukemia NOS	9.4	0.5	0.3-0.6	5.2	0.6	0.4-0.9	4.2	0.4	0.2-0.6	9.4	0.5	0.4-0.7	6.2	0.7	0.5-1.1	3.2	0.3	0.2-0.5
Mesothelioma
Mesothelioma	14.0	0.8	0.6-1.0	9.6	1.2	0.9-1.6	4.4	0.5	0.3-0.7
Kaposi sarcoma
Kaposi sarcoma	4.8	0.3	0.2-0.4	4.4	0.5	0.3-0.8	0.4	0.0	0.0-0.1
Myelodysplastic syndromes
Myelodysplastic syndromes	120.4	6.2	5.7-6.7	68.8	8.6	7.7-9.5	51.6	4.5	4.0-5.1
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^	107.4	5.8	5.3-6.3	54.6	6.6	5.8-7.4	52.8	5.1	4.5-5.8
Ill defined and unspecified sites
Ill defined and unspecified sites	172.2	8.9	8.3-9.6	87.6	10.7	9.7-11.7	84.6	7.7	6.9-8.5	224.6	11.4	10.7-12.1	111.6	13.1	12.0-14.3	113.0	10.1	9.3-11.0

Key

Symbol	Meaning
~	Incidence of skin cancer excludes basal and squamous cell cancers.
*	Breast in situ and Brain/other central nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^	Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

• Incidence data are provisional, November 2022.
• Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
• Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.